Trial Profile
Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors Pfizer
- 01 Sep 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 15 Aug 2013 Planned initiation date changed from 1 Jun 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 10 Jun 2013 Planned initiation date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.